Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

6 of 6 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 2

5(62.5%)

Phase 1

2(25.0%)

Phase 3

1(12.5%)

8Total

Phase 2(5)

Phase 1(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06527937Phase 2Completed

Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

Role: lead

NCT03428360Phase 3Completed

Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy

Role: lead

NCT03222349Phase 2Completed

Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy

Role: lead

NCT03179891Phase 2Completed

Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy

Role: lead

NCT01220167Phase 1Completed

Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

Role: lead

NCT03679975Phase 2Terminated

Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)

Role: lead

NCT03953820Phase 1Completed

Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study

Role: lead

NCT03457753Phase 2Withdrawn

Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis

Role: lead

All 8 trials loaded